A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

February 18, 2020

Study Completion Date

February 18, 2020

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LY3209590

Administered SC

DRUG

Insulin Degludec

Administered SC

Trial Locations (44)

15401

Preferred Primary Care Physicians - Jacob Murphy Lane, Uniontown

19107

Thomas Jefferson University, Philadelphia

20110

Manassas Clinical Research Center, Manassas

20852

Endocrine and Metabolic Consultants, Rockville

28207

Metrolina Internal Medicine, P.A., Charlotte

29621

Internal Medicine Associates of Anderson, Anderson

29662

The Research Center of the Upstate, Mauldin

31217

Investigacion en Salud y Metabolismo S.C, Chihuahua City

33024

ALL Medical Research, LLC, Cooper City

33401

Metabolic Research Institute Inc., West Palm Beach

34652

Suncoast Clinical Research, New Port Richey

35205

Central Research Associates, Inc., Birmingham

50265

Iderc, P.L.C., West Des Moines

64460

Hospital Universitario UANL, Monterrey

66606

Cotton O'Neil Diabetes and Endocrinology Center, Topeka

72205

Arkansas Clinical Research, Little Rock

73069

Intend Research, Norman

75230

Dallas Diabetes Endocrine Center, Dallas

78229

Clinical Trials of Texas, Inc., San Antonio

83221

Elite Clinical Trials LLLP, Blackfoot

83404

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

89128

Palm Research Center, Las Vegas

89148

Palm Research Center, Las Vegas

90057

National Research Institute, Los Angeles

90255

National Research Institute, Huntington Park

92025

AMCR Institute INC, Escondido

92780

University Clinical Investigators, Inc., Tustin

93534

First Valley Medical Group, Lancaster

93720

Valley Endocrine, Fresno, Fresno

94520

John Muir Physician Network Clinical Research Center, Concord

94904

Marin Endocrine Associates, Greenbrae

96814

East West Medical Institute, Honolulu

97330

The Corvallis Clinic P.C., Corvallis

98057

Rainier Clinical Research Center, Renton

98801

Confluence Health Clinical Research Department, Wenatchee

06708

Chase Medical Research, LLC, Waterbury

02721

NECCR PrimaCare Research, LLC, Fall River

03063

Southern New Hampshire Diabetes and Endocrinology, Nashua

78731-4309

Texas Diabetes and Endocrinology, Austin

00961

Advanced Clinical Research, LLC, Bayamón

00674

Manati Center for Clinical Research Inc, Manatí

00917

GCM Medical Group PSC, San Juan

00921

Martha Gomez Cuellar M.D., San Juan

00767

Centro de Endocrinologia del Este, Yabucoa

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03736785 - A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter